The role of erythropoietin in the production of principal erythrocyte proteins other than hemoglobin during terminal erythroid differentiation.
Erythropoietin (EP) controls the terminal phase of differentiation in which proerythroblasts and their precursors, the colony forming units-erythroid (CFU-e), develop into erythrocytes. Biochemical studies of this hormone-directed terminal differentiation have been hindered by the lack of a homogeneous population of erythroid cells at the developmental stages of CFU-e and proerythroblasts that will synchronously differentiate in response to EP. Such a population of cells can be prepared from the spleens of mice with the acute erythroblastosis resulting from infection with anemia-inducing Friend virus (FVA). Using these FVA-infected erythroid cells, which were induced to differentiate with EP, four proteins other than hemoglobin that have key functions in mature erythrocytes were monitored during the 48-hour period of terminal differentiation. Synthesis of spectrin and membrane band 3 proteins were determined by immunoprecipitation and SDS-polyacrylamide gel electrophoresis; accumulation of the cytoskeletal protein band 4.1 was monitored by immunoblotting; carbonic anhydrase activity was measured electrometrically. Band 3 synthesis and band 4.1 accumulation could be detected only after exposure of the cells to EP. Spectrin synthesis was ongoing prior to culture with EP, but it did increase after exposure to the hormone. Carbonic anhydrase-specific activity changed very little throughout the terminal differentiation process. These results reveal at least three patterns of production of principal erythrocyte proteins during EP-mediated terminal differentiation of FVA-infected erythroid cells. Depending on the specific protein examined, de novo synthesis can be induced by EP, an ongoing production can be enhanced by EP, or the production of a protein can be completed at a developmental stage prior to EP-mediated differentiation in these cells.
Koury
M J
MJ
Bondurant
M C
MC
Mueller
T J
TJ
D000818:Animals; D001457:Anion Exchange Protein 1, Erythrocyte / Q000096:biosynthesis; D001797:Blood Protein Electrophoresis; D001798:Blood Proteins / Q000096:biosynthesis*; D002256:Carbonic Anhydrases / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D003598:Cytoskeletal Proteins; D004900:Erythroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000494:pharmacology / Q000502:physiology*; D005260:Female; D005622:Friend murine leukemia virus; D004915:Leukemia, Erythroblastic, Acute / Q000503:physiopathology; D007942:Leukemia, Experimental / Q000503:physiopathology; D008565:Membrane Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D009479:Neuropeptides; D013049:Spectrin / Q000096:biosynthesis; D013154:Spleen / Q000166:cytology
D001457:Anion Exchange Protein 1, Erythrocyte; D001798:Blood Proteins; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D009479:Neuropeptides; C028841:erythrocyte membrane band 4.1 protein; C120557:erythrocyte membrane protein band 4.1-like 1; D004921:Erythropoietin; D013049:Spectrin; D002256:Carbonic Anhydrases